Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Aww so ScienceFirst is Bencro

<< Previous

Bullboard Posts

Next >>

Comment by FGPstockon Apr 18, 2022 10:39pm

141 Views

Post# 34612098

RE:RE:RE:RE:RE:RE:RE:Aww so ScienceFirst is Bencro

Bencro... Which is worse, Roger White admitting he misled investors for 15+ years and being forced out as CEO, or TLT wasting over $100,000 in attorneys fees to get a bunch of default judgments against anonymos posters? If they want to sue me for expresses my opinion they are just wasting more shareholder time and money. The need to focus on running a trial correctly, imo... btw, have you bought any shares yet or still waiting?

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023